par Hoffmann, Paul;Roumeguere, Thierry ;Schulman, Claude ;Van Velthoven, Roland
Référence The New England journal of medicine, 355, 25, page (2705-2707)
Publication Publié, 2006-12
Article révisé par les pairs
Titre:
  • Use of statins and outcome of BCG treatment for bladder cancer.
Auteur:Hoffmann, Paul; Roumeguere, Thierry; Schulman, Claude; Van Velthoven, Roland
Informations sur la publication:The New England journal of medicine, 355, 25, page (2705-2707)
Statut de publication:Publié, 2006-12
Sujet CREF:Cancérologie
MeSH keywords:Adjuvants, Immunologic
BCG Vaccine
Carcinoma in Situ -- therapy
Cholesterol -- blood
Cytokines -- drug effects -- urine
Follow-Up Studies
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors -- adverse effects
Neoplasm Recurrence, Local -- epidemiology
Retrospective Studies
Th1 Cells -- drug effects
Th2 Cells -- drug effects
Treatment Outcome
Urinary Bladder Neoplasms -- therapy
Note générale:Letter
SCOPUS: le.j
Langue:Anglais
Identificateurs:urn:issn:0028-4793
info:doi/10.1056/NEJMc062714
info:pii/355/25/2705
info:scp/33845700951
info:pmid/17183004